Galera Therapeutics Inc (NASDAQ: GRTX) closed the day trading at $0.22 down -4.27% from the previous closing price of $0.23. In other words, the price has decreased by -$0.0100 from its previous closing price. On the day, 1260322 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of GRTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.47 and its Current Ratio is at 2.47.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 10, 2023, Downgraded its rating to Neutral and sets its target price to $0.50 from $6 previously.
BofA Securities Downgraded its Buy to Underperform on October 19, 2021, whereas the target price for the stock was revised from $17 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 08 ’24 when Schneid Yair bought 150,000 shares for $0.17 per share. The transaction valued at 25,650 led to the insider holds 8,043,203 shares of the business.
Schneid Yair bought 175,000 shares of GRTX for $30,185 on Feb 07 ’24. The 10% Owner now owns 7,893,203 shares after completing the transaction at $0.17 per share. On Feb 06 ’24, another insider, Schneid Yair, who serves as the 10% Owner of the company, bought 25,000 shares for $0.20 each. As a result, the insider paid 5,025 and bolstered with 7,718,203 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GRTX now has a Market Capitalization of 12.70M and an Enterprise Value of -14.38M.
Stock Price History:
Over the past 52 weeks, GRTX has reached a high of $3.59, while it has fallen to a 52-week low of $0.09. The 50-Day Moving Average of the stock is 0.2032, while the 200-Day Moving Average is calculated to be 0.7403.
Shares Statistics:
Over the past 3-months, GRTX traded about 2.01M shares per day on average, while over the past 10 days, GRTX traded about 504.94k shares per day. A total of 54.39M shares are outstanding, with a floating share count of 38.25M. Insiders hold about 29.69% of the company’s shares, while institutions hold 14.87% stake in the company. Shares short for GRTX as of Feb 29, 2024 were 5.09M with a Short Ratio of 2.53, compared to 3.5M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.36% and a Short% of Float of 9.45%.
Earnings Estimates
Current recommendations for the stock of the company come from 0 analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.58. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
